Recombinant Ashbya gossypii Enhancer of translation termination 1 (ETT1)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: We will prioritize shipping the format currently in stock. If you have specific format requirements, please indicate them during order placement.
Lead Time
Delivery times vary depending on the purchase method and location. Please consult your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs unless otherwise requested. Dry ice shipping requires prior communication and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50% and may serve as a guideline.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The specific tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
ETT1; AGR299WEnhancer of translation termination 1
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-411
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) (Yeast) (Eremothecium gossypii)
Target Names
ETT1
Target Protein Sequence
MTKRPLGLGK KNKQKRHKPD EGADGKKEST PLDQIHVEVE GGGDPEDSVV QLKALWRNYL QSEREDERVL NGIVHECDRL LRNREQEGIE LGEDFHSIYA LALSELAIFR TEEKGQAGRE SVGEFFDAAA ERVDMGLQHF PASDVLALAK AKIIFQRIPL QYVSQLSPNN SEGADVGLQQ LLEEGKSSFR VVAQDPLAVS EPLEIFSDLL EIIANFGRED EIDEGLDSDA EDEPEEVELP ESHPLYELRQ HLPEHAEWLQ QQLLALFKVL EKPNAEEEES EATKFYRKIA NKLGQSYLDA AAEPSIVFTT LTYETEDPSA EDEQKAQEAQ RVAQGLTERA IEFFKEAESA DDPQTWVDTA EVFISLGNLQ ENESETQEML YKQAEEKMVR ANKATNGKYK HILDTLLDSK T
Uniprot No.

Target Background

Function

This protein is essential for accurate translation termination and is likely involved in regulating hypoxic gene expression.

Database Links
Protein Families
ETT1 family
Subcellular Location
Nucleus.

Q&A

What is Ashbya gossypii and why is it valuable as a model organism for recombinant protein studies?

Ashbya gossypii is a filamentous fungus that is closely related to unicellular yeasts such as Saccharomyces cerevisiae. It has gained significant attention in molecular biology research due to several advantageous characteristics:

  • It has close phylogenetic ties to well-studied yeasts while exhibiting filamentous growth, making it ideal for comparative studies between different fungal growth forms

  • The complete genome sequence is available, facilitating genetic manipulation

  • It serves as an excellent model for studying the regulatory networks governing filamentous versus unicellular growth

  • The genetic toolbox for A. gossypii has been continuously expanding, enabling sophisticated molecular studies

  • Its relation to dimorphic fungi like Candida albicans provides insights into morphological switches relevant to fungal pathogenicity

These features make A. gossypii particularly valuable for studying proteins involved in translation processes, including factors like ETT1 .

What molecular tools are available for expressing recombinant proteins in Ashbya gossypii?

A variety of molecular tools have been developed for efficient genetic manipulation and protein expression in A. gossypii:

Promoter options:

  • Strong constitutive promoters: PGPD1, PTEF, and PPGK1 for high-level expression

  • Medium/weak promoters: PTSA1, PHSP26, PAGL366C, PTMA10, PCWP1, PAFR038W, and PPFS1 for moderate expression

  • Newly characterized strong promoters: PCCW12, PSED1 for robust expression

Selection markers:

  • loxP-kanMX-loxP cassettes for G418 resistance that can be eliminated and reused through Cre recombinase expression

Expression validation systems:

  • Dual luciferase reporter assays using Renilla and firefly luciferase to quantitatively measure promoter strength

  • Integration of expression cassettes at specific genomic loci (e.g., ADR304W and AGL034C) for stable expression

When designing expression systems for ETT1, these tools provide a framework for optimizing recombinant protein production with precise control over expression levels.

How are integration cassettes designed for recombinant protein expression in A. gossypii?

The design of integration cassettes for recombinant protein expression in A. gossypii typically follows this structure:

  • Recombinogenic flanks targeting specific genomic loci (e.g., ADR304W and AGL034C)

  • A selectable marker (such as loxP-KanMX-loxP for G418 resistance)

  • A promoter sequence of appropriate strength for the desired expression level

  • The target gene's coding sequence (CDS)

  • A terminator sequence (commonly from PGK1)

This design ensures stable genomic integration and controlled expression. For verifying successful integration, analytical PCR followed by DNA sequencing is employed. Additionally, marker elimination through transient Cre recombinase expression allows marker reuse for sequential genetic modifications .

What promoter strengths should be considered for optimal ETT1 expression in A. gossypii?

When selecting promoters for ETT1 expression in A. gossypii, consider their relative strengths based on experimental validation. The following table compares relative activities of various promoters in A. gossypii based on luciferase reporter assays:

Promoter CategorySpecific PromotersRelative StrengthBest Application
Strong PromotersPCCW12, PSED1, PGPD1High (75-100%)Overexpression studies, high-yield protein production
Medium PromotersPTSA1, PHSP26, PAGL366CModerate (30-75%)Physiological expression levels, functional studies
Weak PromotersPTMA10, PCWP1, PAFR038W, PPFS1Low (5-30%)Minimal complementation, studying proteins toxic at high levels

For ETT1 expression, the choice of promoter should align with research objectives. Strong promoters like PGPD1 are suitable for biochemical and structural studies requiring high protein yields, while moderate or weak promoters may be more appropriate for functional studies where physiological expression levels are desired .

How can I validate the integration and expression of recombinant ETT1 in A. gossypii?

Validating both integration and expression of recombinant ETT1 in A. gossypii requires a multi-step approach:

Genomic integration confirmation:

  • Analytical PCR using primers spanning the integration junctions

  • DNA sequencing of PCR products to verify exact integration sites

  • Southern blot analysis for complex integration events

Expression validation:

  • RT-PCR or qRT-PCR to confirm transcription

  • Western blot analysis using antibodies against ETT1 or an epitope tag

  • Functional assays measuring translation termination efficiency

  • Dual luciferase reporter systems can be adapted to measure termination efficiency

For quantitative expression analysis, the dual luciferase system described in the literature provides excellent normalization capabilities. The reference strain A947 containing both Renilla and firefly luciferase expressed from PGPD1 can serve as a calibration control .

What considerations are important when designing experiments to study ETT1 function in A. gossypii?

When designing experiments to study ETT1 function in A. gossypii, consider these critical factors:

Experimental design principles:

  • Include appropriate replicates (minimum 2-3, ideally 5 biological replicates)

  • Implement factorial designs to study interactions between ETT1 and other factors

  • Control for batch effects by balanced distribution of samples

  • Avoid confounding variables by proper randomization

  • Include proper controls (wild-type, vector-only, inactive ETT1 mutant)3

Common pitfalls to avoid:

  • Unbalanced experimental designs (e.g., 20 samples in one group vs. 5 in another)

  • Failure to account for batch effects that can be misinterpreted as biological differences

  • Incomplete factorial designs that limit statistical power

  • Confounding effects from improper sample distribution across experimental variables3

How can I study the interaction between ETT1 and the ribosomal machinery in A. gossypii?

Studying ETT1 interactions with the ribosomal machinery in A. gossypii requires sophisticated approaches:

In vivo approaches:

  • Fluorescence microscopy with GFP-tagged ETT1 to track localization to ribosomes

  • Bimolecular fluorescence complementation (BiFC) to visualize direct interactions

  • Fluorescence resonance energy transfer (FRET) for detecting proximity of ETT1 to ribosomal proteins

  • Time-lapse fluorescence microscopy to track dynamic interactions during translation

Biochemical approaches:

  • Co-immunoprecipitation with ribosomal proteins followed by mass spectrometry

  • Polysome profiling to detect ETT1 association with translating ribosomes

  • Ribosome footprinting to map ETT1 binding sites

  • Crosslinking and immunoprecipitation (CLIP) to identify RNA interaction sites

The methodologies used for studying Rsr1p/Bud1p localization and interaction with the actin cytoskeleton in A. gossypii provide a template for studying protein-protein interactions in this organism. In that study, fluorescently labeled proteins were used to track localization patterns and dynamic changes during hyphal growth .

What strategies can be employed to investigate the impact of ETT1 mutations on translation termination efficiency?

To investigate how mutations in ETT1 affect translation termination efficiency in A. gossypii, consider these approaches:

Genetic modification strategies:

  • CRISPR/Cas9-based targeted mutagenesis of conserved domains

  • Alanine scanning mutagenesis of putative functional residues

  • Domain swapping with orthologs from related species

  • Construction of temperature-sensitive alleles for conditional studies

Functional assays:

  • Dual luciferase reporters with premature termination codons

  • Measurement of stop codon readthrough rates using fluorescent reporters

  • Ribosome profiling to detect changes in ribosome stalling at termination codons

  • Analysis of mRNA decay patterns related to nonsense-mediated decay

Comparative analysis:

  • Sequence comparison with the well-characterized S. cerevisiae translation machinery

  • Structural modeling based on homology to known termination factors

  • Evolutionary analysis of conserved residues across fungal species

The high degree of similarity observed between A. gossypii and S. cerevisiae genes (for example, the TEF gene shows 88.6% identity at DNA level and 93.7% at protein level) suggests that functional domains may be conserved, providing guidance for targeted mutagenesis approaches .

How can I optimize the purification of recombinant ETT1 from A. gossypii for structural studies?

Purifying recombinant ETT1 from A. gossypii for structural studies requires careful optimization:

Expression optimization:

  • Select the strongest appropriate promoter (e.g., PGPD1, PCCW12, or PSED1)

  • Optimize codon usage based on A. gossypii preferences

  • Consider adding a secretion signal for extracellular expression

  • Use controlled fermentation conditions to maximize biomass

Purification strategy:

  • Design an affinity tag system (His6, FLAG, or GST) with a TEV protease cleavage site

  • Develop a multi-step purification protocol:

    • Initial capture by affinity chromatography

    • Ion exchange chromatography for charge-based separation

    • Size exclusion chromatography for final polishing

  • Optimize buffer conditions for protein stability

  • Consider on-column tag removal for native protein studies

Quality control:

  • SDS-PAGE and Western blotting to verify purity

  • Mass spectrometry for identity confirmation

  • Dynamic light scattering to assess aggregation state

  • Thermal shift assays to evaluate stability in different buffers

Structural analysis preparations:

  • Concentrate to ≥10 mg/mL for crystallization trials

  • Screen stability in various buffer conditions

  • Test protein activity to ensure proper folding

  • Consider surface entropy reduction mutations to facilitate crystallization

The methodologies used for expressing and purifying other fungal proteins can be adapted for ETT1, with appropriate modifications based on its specific biochemical properties.

What approaches can be used to resolve contradictory data regarding ETT1 function?

When encountering contradictory data in ETT1 functional studies, consider these systematic approaches:

Sources of variability to investigate:

  • Strain background differences

  • Expression level variations due to promoter choice

  • Growth condition variations (media composition, temperature, growth phase)

  • Assay-specific technical artifacts

  • Unrecognized batch effects or confounding variables3

Resolution strategies:

  • Design controlled experiments that directly address contradictions

  • Employ multiple complementary techniques to study the same phenomenon

  • Collaborate with other labs to independently verify results

  • Perform statistical meta-analysis of combined datasets

  • Consider whether apparent contradictions reflect context-dependent functions

Statistical approaches:

  • Power analysis to ensure adequate sample sizes

  • Mixed-effects models to account for batch effects and other random factors

  • Bayesian analysis to incorporate prior knowledge

  • Sensitivity analysis to identify parameters driving contradictory results

Experimental design principles highlighted in the literature emphasize the importance of controlling for batch effects, using balanced designs, and avoiding confounding variables, all of which are critical for generating reliable and reproducible data3.

How can I design gene deletion and complementation experiments to study ETT1 function in A. gossypii?

Creating and complementing ETT1 deletions in A. gossypii requires careful experimental design:

Deletion strategy:

  • Design deletion cassettes with long homology arms (40-60 bp) flanking the ETT1 coding region

  • Include a selectable marker (e.g., loxP-kanMX-loxP) for transformant selection

  • Transform A. gossypii with the deletion cassette using polyethylene glycol-mediated transformation

  • Select primary heterokaryotic transformants on G418-containing medium

  • Isolate homokaryotic clones through sporulation

  • Verify gene deletion by analytical PCR and sequencing

Complementation approaches:

  • Reintroduce ETT1 under its native promoter at its original locus

  • Express ETT1 under control of various strength promoters to assess dosage effects

  • Introduce ETT1 at a neutral genomic locus (e.g., ADR304W or AGL034C)

  • Use the Cre-loxP system to remove selection markers for multiple modifications

Phenotypic analysis:

  • Growth rate comparisons under various conditions

  • Microscopic analysis of hyphal morphology and development

  • Protein synthesis rate measurements using metabolic labeling

  • Translational fidelity assays using reporter constructs

The approaches used for analysis of gene function in A. gossypii, such as those demonstrated for the Rsr1p/Bud1p GTPase, provide relevant methodological frameworks that can be adapted for ETT1 functional studies .

What are the key considerations for designing a CRISPR/Cas9-based genome editing system for ETT1 in A. gossypii?

Implementing CRISPR/Cas9 genome editing for ETT1 in A. gossypii requires attention to several technical aspects:

CRISPR/Cas9 design considerations:

  • Codon-optimize Cas9 for expression in A. gossypii

  • Select appropriate promoters for Cas9 and sgRNA expression

  • Design sgRNAs targeting ETT1 with minimal off-target effects

  • Create repair templates with homology arms for precise modifications

  • Consider using a ribonucleoprotein (RNP) delivery approach to avoid genomic integration of Cas9

Target selection criteria:

  • Identify PAM sites (NGG for SpCas9) within the ETT1 coding sequence

  • Prioritize targets in conserved functional domains

  • Verify target uniqueness using the A. gossypii genome sequence

  • Design sgRNAs with optimal GC content (40-60%) and minimal secondary structure

Editing verification:

  • PCR amplification and sequencing of the target region

  • T7 endonuclease I assay for detecting indels

  • Restriction fragment length polymorphism analysis if editing creates/removes restriction sites

  • Functional assays to confirm phenotypic consequences

The molecular tools developed for A. gossypii, including promoters of varying strengths and well-characterized genomic integration sites, provide a foundation for developing efficient CRISPR/Cas9 systems in this organism .

How can I integrate omics approaches to develop a systems-level understanding of ETT1 function in A. gossypii?

Integrating multiple omics approaches can provide comprehensive insights into ETT1 function:

Multi-omics strategy:

  • Transcriptomics: RNA-seq to identify genes affected by ETT1 deletion or overexpression

  • Proteomics: Mass spectrometry to detect changes in protein abundance and post-translational modifications

  • Ribosome profiling: Identify translational changes and ribosome stalling events

  • Interactomics: Immunoprecipitation-mass spectrometry to map protein interaction networks

  • Metabolomics: Detect metabolic shifts resulting from altered translation termination

Data integration approaches:

  • Correlation network analysis to identify functional relationships

  • Pathway enrichment analysis to determine biological processes affected

  • Causal network modeling to infer regulatory relationships

  • Machine learning for pattern recognition across datasets

Experimental design considerations:

  • Include appropriate time points to capture dynamic responses

  • Maintain consistent experimental conditions across omics platforms

  • Include biological replicates (minimum 3, ideally 5) for statistical robustness

  • Control for batch effects through randomization and blocking designs3

The experimental design principles discussed in the literature regarding factorial design, blocking, and controlling for batch effects are particularly relevant when planning complex omics experiments to ensure valid statistical analysis and meaningful biological interpretation3.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.